DBV Technologies (DBVT) Competitors $15.88 +1.64 (+11.52%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$17.40 +1.52 (+9.58%) As of 08:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DBVT vs. BGM, SYRE, RAPP, SPRY, TNGX, PHAR, IMTX, UPB, RLAY, and TSHAShould you be buying DBV Technologies stock or one of its competitors? The main competitors of DBV Technologies include BGM Group (BGM), Spyre Therapeutics (SYRE), Rapport Therapeutics (RAPP), ARS Pharmaceuticals (SPRY), Tango Therapeutics (TNGX), Pharming Group (PHAR), Immatics (IMTX), Upstream Bio (UPB), Relay Therapeutics (RLAY), and Taysha Gene Therapies (TSHA). These companies are all part of the "pharmaceutical products" industry. DBV Technologies vs. Its Competitors BGM Group Spyre Therapeutics Rapport Therapeutics ARS Pharmaceuticals Tango Therapeutics Pharming Group Immatics Upstream Bio Relay Therapeutics Taysha Gene Therapies DBV Technologies (NASDAQ:DBVT) and BGM Group (NASDAQ:BGM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Does the media refer more to DBVT or BGM? In the previous week, DBV Technologies had 3 more articles in the media than BGM Group. MarketBeat recorded 4 mentions for DBV Technologies and 1 mentions for BGM Group. DBV Technologies' average media sentiment score of 0.79 beat BGM Group's score of 0.00 indicating that DBV Technologies is being referred to more favorably in the media. Company Overall Sentiment DBV Technologies Positive BGM Group Neutral Do insiders and institutionals hold more shares of DBVT or BGM? 71.7% of DBV Technologies shares are owned by institutional investors. 1.4% of DBV Technologies shares are owned by company insiders. Comparatively, 58.7% of BGM Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings & valuation, DBVT or BGM? BGM Group has higher revenue and earnings than DBV Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDBV Technologies$4.15M104.85-$113.92M-$4.77-3.33BGM Group$25.10M38.27-$1.44MN/AN/A Which has more risk and volatility, DBVT or BGM? DBV Technologies has a beta of -0.45, suggesting that its share price is 145% less volatile than the S&P 500. Comparatively, BGM Group has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Do analysts recommend DBVT or BGM? DBV Technologies presently has a consensus price target of $14.75, suggesting a potential downside of 7.12%. Given DBV Technologies' stronger consensus rating and higher possible upside, analysts plainly believe DBV Technologies is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DBV Technologies 2 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.43BGM Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is DBVT or BGM more profitable? BGM Group has a net margin of 0.00% compared to DBV Technologies' net margin of -3,220.49%. BGM Group's return on equity of 0.00% beat DBV Technologies' return on equity.Company Net Margins Return on Equity Return on Assets DBV Technologies-3,220.49% -287.15% -138.83% BGM Group N/A N/A N/A SummaryDBV Technologies beats BGM Group on 8 of the 15 factors compared between the two stocks. Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DBVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DBVT vs. The Competition Export to ExcelMetricDBV TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$390.11M$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-3.3321.5785.5627.61Price / Sales104.85271.42535.65201.06Price / CashN/A47.1237.9261.55Price / Book11.1810.1413.036.76Net Income-$113.92M-$52.31M$3.30B$275.88M7 Day Performance29.63%5.14%4.35%2.81%1 Month Performance68.94%14.68%9.50%9.24%1 Year Performance350.50%30.98%85.16%35.42% DBV Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DBVTDBV Technologies1.5712 of 5 stars$15.88+11.5%$14.75-7.1%+344.0%$390.11M$4.15M-3.3380Analyst ForecastGap UpHigh Trading VolumeBGMBGM Group0.2453 of 5 stars$9.61-5.4%N/A+34.4%$987.78M$25.10M0.00298News CoveragePositive NewsAnalyst ForecastGap DownSYRESpyre Therapeutics3.2735 of 5 stars$16.36+0.7%$54.29+231.8%-36.6%$980.91M$890K-4.8173Analyst DowngradeRAPPRapport Therapeutics3.0183 of 5 stars$27.97+5.2%$35.33+26.3%+37.3%$970.48MN/A-11.19N/AAnalyst ForecastGap UpSPRYARS Pharmaceuticals2.9139 of 5 stars$9.72-0.8%$33.17+241.2%-20.0%$968.50M$112.34M-19.8490Analyst ForecastTNGXTango Therapeutics1.9692 of 5 stars$8.44-1.1%$10.50+24.4%+0.3%$949.05M$24.30M-6.3590Analyst ForecastPHARPharming Group2.3119 of 5 stars$14.29+3.6%$30.00+109.9%+69.5%$944.82M$339.84M-109.92280Analyst ForecastShort Interest ↑IMTXImmatics2.4272 of 5 stars$7.91+2.7%$15.00+89.6%-5.5%$935.94M$168.65M-12.17260Analyst ForecastUPBUpstream Bio1.8817 of 5 stars$17.34+0.5%$56.50+225.8%N/A$930.47M$2.72M0.0038Analyst ForecastRLAYRelay Therapeutics2.8201 of 5 stars$5.19+0.4%$16.50+217.9%-2.2%$891.37M$10.01M-2.66330Positive NewsTSHATaysha Gene Therapies2.5199 of 5 stars$3.16-2.8%$8.29+162.2%+151.7%$886.58M$8.33M-9.29180Analyst ForecastGap Up Related Companies and Tools Related Companies BGM Group Alternatives Spyre Therapeutics Alternatives Rapport Therapeutics Alternatives ARS Pharmaceuticals Alternatives Tango Therapeutics Alternatives Pharming Group Alternatives Immatics Alternatives Upstream Bio Alternatives Relay Therapeutics Alternatives Taysha Gene Therapies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DBVT) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
